Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.C100767200 on June 7, 2002

J. Biol. Chem., Vol. 277, Issue 31, 28065-28069, August 2, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/31/28065    most recent
C100767200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, Y.
Right arrow Articles by Seino, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, Y.
Right arrow Articles by Seino, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Identification, Tissue Expression, and Functional Characterization of Otx3, a Novel Member of the Otx Family*

Yan ZhangDagger , Takashi MikiDagger §, Toshihiko Iwanaga, Yoko Koseki||, Masaaki OkunoDagger , Yasuhiro SunagaDagger , Nobuaki OzakiDagger , Hideki YanoDagger , Haruhiko Koseki||, and Susumu SeinoDagger **

From the Departments of Dagger  Cellular and Molecular Medicine and || Molecular Embryology, Graduate School of Medicine, and § Gene Research Center, Chiba University, Chiba 260-8670, Japan and the  Laboratory of Anatomy, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo 060-0818, Japan

Received for publication, December 30, 2001, and in revised form, May 29, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Transcription factors containing a homeodomain play an important role in the organogenesis of vertebrates. We have isolated a novel homeodomain transcription factor, Otx3, which is structurally and functionally related to Otx1 and Otx2, transcription factors that are critical in brain morphogenesis. Mouse Otx3 is a protein composed of 376 amino acids. Otx3 mRNA was expressed in mouse embryos from 10.5 to 13.5 days postcoitum (dpc) and in adult cerebellum as assessed by Northern blotting. Whole-mount in situ hybridization of mouse embryos from 9.5 to 11.5 dpc revealed strong expression of Otx3 mRNA in the diencephalon, mesencephalon, metencephalon, myelencephalon, and developing eye, indicating an expression pattern largely overlapping but distinct from those of Otx1 and Otx2. In addition, Otx3 was shown by electrophoretic mobility shift assay to bind to the TAATCC motif, the consensus binding sequence for Otx1, Otx2, and Crx. Results of a transcription reporter assay suggest that Otx3 functions as a transcription repressor by binding to this motif. These results suggest that Otx3 is a novel member of the Otx family and may be involved in the development of the central nervous system.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Many signal molecules and transcription factors are required in the control of induction, specification, and regionalization of the CNS1 in vertebrates (1, 2). Most of them have been identified as genes homologous to those in Drosophila (1, 2) in which the patterning of the neural primordium has been studied extensively. Among them, the Otx family (Otx1, Otx2, and Crx), the vertebrate homologues of orthodenticle (otd), possesses a bicoid (Bcd)-like homeodomain and has been shown to play an important role in brain morphogenesis in vertebrates (3). During murine embryogenesis, Otx1 expression is detected first at the early stage of 8.2-8.5 dpc throughout the forebrain and midbrain neuroepithelium and in developing sense organs (4, 5). From birth day onward, Otx1 also is expressed at a relatively low level in the anterior lobe of the pituitary gland (6). Studies of mutant mouse models suggest that Otx1 is involved in corticogenesis, sense organ development, and pituitary function (3). Otx2 is expressed at an earlier developmental stage than Otx1. In mouse, Otx2 already is expressed before the onset of gastrulation in the epiblast and in the visceral endoderm at 5.5 dpc (5) and also in the headfold at 7.5 dpc (4). After 8.5 dpc, the expression pattern of Otx2 largely overlaps that of Otx1 with a posterior border at the mesencephalic side of the isthmic constriction during brain regionalization (3, 4). Crx also was identified as a member of the Otx family (7). The expression of Crx is highly restricted to retina where it is profoundly involved in differentiation and maintenance of retinal neurons. HD proteins are thought to be involved in development and differentiation not only in central and peripheral neurons but also in endocrine and neuroendocrine cells (6, 8). It has been shown that many transcription factors necessary in the development of the CNS also are involved in the development of insulin-secreting pancreatic beta  cells (9). We hypothesized that known or novel HD transcription factors expressed in pancreatic beta  cells participate in their development by organizing the regulated expression of the various other transcription factors.

In the present study, we have identified a novel HD transcription factor from a pancreatic beta  cell line that is highly expressed in brain. It possesses a Bcd-like HD structurally and functionally related to that of Otx1 and Otx2 and has been designated Otx3. Our findings suggest that Otx3 may play an important role in brain morphogenesis.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Screening of cDNA Library-- A partial cDNA fragment was amplified from the mouse pancreatic beta  cell line MIN6 by reverse transcriptase PCR using fully degenerate primers corresponding to the following amino acid sequences: R(S/E)RT(T/A)FT and QVWFKNR, both of which are highly conserved among most HD proteins. The bands of interest from the PCR were excised from a 2% agarose gel and then subcloned and sequenced. A DNA fragment having a novel HD was identified. This cDNA fragment was used as a probe to screen the MIN6 cDNA library under high stringency hybridization conditions to isolate the full-length cDNA encoding Otx3.

Northern Blot Analysis-- RNA was extracted from adult Sprague-Dawley rat tissues and cell lines, and 20 µg of total RNA were electrophoresed on a 1% agarose-formaldehyde gel and transferred to a nylon membrane. The Northern blot of full stage (4.5-18.5 dpc) mouse embryos was purchased from Seegene (Seoul, Korea), each line containing 20 µg of total RNA. An 802-bp fragment of Otx3 cDNA (nt 1-802), a full-length coding region of Otx1 cDNA, and a 523-bp fragment of Otx2 cDNA (nt 103-625) were used as probes for the hybridization of Northern blots. Hybridization was performed under standardized conditions. Membranes were washed with 0.1× SSC and 0.1% SDS at room temperature for 1 h and at 50 °C for 1 h before autoradiography.

In Situ Hybridization-- Whole-mount and section RNA in situ hybridization was performed as described previously (10). The cRNA probes for Otx1 and Otx2 were synthesized based on the sequences from GenBankTM accession numbers AF424700 and P80206, respectively. Otx1 and Otx2 cDNAs were amplified by PCR from a mouse brain cDNA library using specific primers and subcloned into pGEM-T easy vector (Promega, Madison, WI). For whole-mount in situ hybridization, digoxigenin-labeled riboprobes were synthesized using linearized DNA templates in pBluescript vector (Otx3) (Stratagene, La Jolla, CA) and pGEM-T easy vector (Otx1 and Otx2). Transcription reactions were carried out according to the manufacturer's instructions using T3 (for Otx3) and SP6 (for Otx1 and Otx2) RNA polymerase (Promega) in the presence of a digoxigenin-NTP mixture. For in situ hybridization of Otx3 on embryo sections, 35S-labeled riboprobes were synthesized using T3 RNA polymerase in the presence of 35S-UTP (Amersham Biosciences).

EMSA-- For EMSA, a partial Otx3 protein (aa 76-148) was expressed as a glutathione S-transferase (GST) fusion protein in Escherichia coli using pGEX4T-1 vector (Amersham Biosciences) and purified by glutathione-Sepharose beads (Amersham Biosciences). The HD-containing peptide of Otx2 (aa 34-208) was produced using the same method. Oligonucleotide sequences used as labeled probes in EMSA were as follows: HD consensus sequence, 5'-CAGTAAGCCTTTAATCCTGTCT-3' and its exact complement; mutant HD consensus sequence, 5'-CAGTAAGCCAGATCTCCTGTCT-3' and its exact complement. The HD consensus sequence contains the binding sequence (TAATCC) for Otx1, Otx2, and Crx. This sequence is disrupted in the mutant HD consensus sequence. The double-stranded probe was 32P-radiolabeled with polynucleotide kinase (New England Biolabs, Beverly, MA). The radiolabeled probe was mixed with in vitro translated proteins, and EMSA was performed as described previously (11).

Transfection and Luciferase Assay-- The Otx3 expression vector (pCMV-Otx3) and the Otx2 expression vector (pCMV-Otx2) were generated by subcloning the entire coding region of mouse Otx3 cDNA and partial mouse Otx2 cDNA (nt 100-867) into pcDNA3.1(-) (Invitrogen), respectively. A chimeric construct (Otx3N/Otx2C) consisting of the N terminus of mouse Otx3 (aa 1-125) and the C terminus of mouse Otx2 (aa 98-289) was generated and subcloned into pcDNA3.1(-), which contains the HD domain of Otx3 and OTX-tail of Otx2 (7). Reporter plasmid (pP3Ctk-Luc) was generated to express luciferase under the control of thymidine kinase (tk) minimal promoter linked to triple repeats (P3C) of the synthesized oligonucleotide containing the consensus binding sequence (TAATCC) for the Otx family. Neuroendocrine-derived GH3 cells were used for the transcription reporter assay. Cells on 3.5-cm dishes were transfected with a total of 1 µg of DNA containing 250 ng of pP3Ctk-Luc and 100 ng of pAct-beta -gal with or without the various Otx constructs described above. Activity was assayed in cells transfected with 250 ng of Otx3 alone, 250 ng of Otx2 alone, 250 ng of Otx2 plus 250 ng of Otx3, or 250 ng of Otx3N/Otx2C alone. The total amount of DNA was adjusted to 1 µg by adding empty vector DNA. Two days after transfection, the cells were harvested, and luciferase activity and beta -galactosidase (beta -gal) activity were measured. pAct-beta -gal, which expresses beta -gal, was co-transfected to normalize transfection efficiency.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Otx3 Is a Novel Member of the HD Gene Family-- Since a partial DNA fragment obtained from degenerate PCR was suggested to be a novel transcription factor, its full-length cDNA was isolated from a mouse MIN6 cDNA library and sequenced (Fig. 1A). Sequence analysis revealed a novel member belonging to the HD gene family that was designated mouse Otx3 (GenBankTM accession number AB037698). The deduced open reading frame encodes 376 amino acids with a predicted mass of 40 kDa. The HD of mouse Otx3 shows homology to HD-containing transcription factors including members of the Pax, HOX, and Pitx families. Among these, Otx3 has the highest amino acid identity with Otx1, Otx2, and Crx (65% for each one). Further, it possesses a lysine at the 50th amino acid residue in the HD, a feature shared by all of the members of the Otx family, while Otx3 lacks the so-called OTX-tail that is conserved among the other Otx members (7) (Fig. 1B). However, Otx3 lacks the other known domains, including the paired, HOX, and POU domains present in the Pax, HOX, and Pitx families. We also have identified a human full-length Otx3 cDNA (GenBankTM accession number AB037699) from a fetal brain cDNA library (BD Biosciences CLONTECH, Palo Alto, CA). The amino acid identity between mouse and human Otx3 is 94.4% (data not shown).


View larger version (58K):
[in this window]
[in a new window]
 
Fig. 1.   Structures of the Otx family and Northern blot analysis of Otx3. A, the deduced amino acid sequence of mouse Otx3 cDNA is shown. The boxed amino acid sequence corresponds to the HD. The lysine residue at the 50th position in the HD is indicated by an asterisk. B, structures of members of the Otx family. Schematic structures of Otx3, Otx1, Otx2, and Crx are shown. Hatched, solid, and shaded boxes indicate HD, lysine residue, and OTX-tail, respectively. C, Otx3 mRNA expression in rat adult tissues and endocrine cell lines. Each lane contains 20 µg of total RNA. A single abundant transcript of 4.3 kb (indicated by an arrow) is detected in MIN6 cells and adult cerebellum. Skeletal m., skeletal muscle; Islets, pancreatic islets. D, Otx3 mRNA expression during mouse development. An arrow indicates a single transcript of about 4.3 kb from 10.5 to 13.5 dpc in mouse embryonic stages.

Expression of Otx3 mRNA in Adult Rat Tissues, Cell Lines, and Embryos-- To examine the tissue expression pattern of Otx3, total RNA from various adult rat tissues, endocrine cell lines, and mouse embryos at 4.5-18.5 dpc was analyzed by Northern blotting. A single abundant transcript of 4.3 kb was detected in MIN6 and adult cerebellum, but no signal was observed in adult pancreatic islets or the other cells and tissues (Fig. 1C). However, expression in adult pancreatic islets was demonstrated by reverse transcriptase PCR with Otx3-specific primers (data not shown). During embryogenesis, the Otx3 transcript was detected from 10.5 to 13.5 dpc in mouse embryos (Fig. 1D). To compare the expression pattern of Otx3 with Otx1 and Otx2 during mouse development, the expression of Otx1 and Otx2 also was evaluated in the same blot (data not shown). A single Otx1 transcript of about 3.5 kb was detected from 10.5 to 15.5 dpc in mouse embryos. Although a single Otx2 transcript of about 3.3 kb was detected from 7.5 to 18.5 dpc in mouse embryos, most abundant Otx2 mRNA was detected from 10.5 to 13.5 dpc. The temporal expression pattern of Otx3 overlaps that of Otx1 and Otx2 during embryogenesis, especially from 10.5 to 13.5 dpc.

Spatial Expression Pattern of Otx3 in Mouse Embryos-- To investigate Otx3 expression at early midgestational stages of mouse development and to obtain more detailed information on the localization of Otx3 mRNA expression in the embryos, we performed whole-mount in situ hybridization of mouse embryos from 8.5 to 11.5 dpc (Fig. 2A, A1-A3). For comparison, whole-mount in situ hybridization of Otx2 (Fig. 2A, A4-A6) and Otx1 (Fig. 2A, A7-A9) also were performed in mouse embryos from 9.5 to 11.5 dpc. At 8.5 dpc, Otx3 transcripts were detected in the prospective midbrain region and preoptic placode (data not shown). From 9.5 to 11.5 dpc, Otx3 expression was craniocaudally delimited to the rostral region of the developing nervous system (Fig. 2A, A1-A3). In 9.5 dpc embryos, the anterior and posterior boundaries of Otx3 expression coincide with those of the diencephalon and mesencephalon, respectively (Fig. 2A, A1). Beginning from 10.5 dpc, Otx3 expression progressively declines in the anterior region, and the most intense hybridization signal coincides with the midbrain-hindbrain boundary (Fig. 2A, A2, arrowhead). In addition, Otx3 expression was observed in the developing eye (Fig. 2A, A2 and A3). At 11.5 dpc, Otx3 expression is enhanced gradually in a craniocaudal direction within the mesencephalon, metencephalon, and myelencephalon (Fig. 2A, A3).


View larger version (60K):
[in this window]
[in a new window]
 
Fig. 2.   In situ hybridization analyses of mouse embryos. A, whole-mount in situ hybridization. Expression of Otx3 (A1-A3), Otx2 (A4-A6), and Otx1 (A7-A9) in 9.5 dpc (A1, A4, and A7), 10.5 dpc (A2, A5, and A8), and 11.5 dpc (A3, A6, and A9) mouse embryos. An arrowhead indicates the midbrain-hindbrain boundary. A10-A12, expression patterns of Otx1 (yellow), Otx2 (red), and Otx3 (blue) in the developing CNS at 9.5, 10.5, and 11.5 dpc mouse embryos. Te, telencephalon; Di, diencephalon; Ms, mesencephalon; Mt, metencephalon; My, myelencephalon; Oc, optic cups. B, in situ hybridization in sections: Otx3 expression of mesencephalon in transverse sections at 10.5 dpc (B1 and B2) and sagittal sections of whole-mount mouse embryos at 13.5 dpc (B3 and B4). The bright field image shown in B2 corresponds to the dark field image shown in B1. B4 is a higher magnification of the boxed region in B3. Scale bar, 200 µm.

To investigate Otx3 expression along the dorsoventral axis, we performed in situ hybridization on transverse sections through the mesencephalon of 10.5 dpc embryos and found that Otx3 is expressed, but not in the floor plate (Fig. 2B, B1 and B2). In 13.5 dpc embryos, Otx3 expression is present in the mesencephalon and extends posteriorly to regions of the metencephalon and myelencephalon as shown in sagittal sections (Fig. 2B, B3 and B4). Similarly to Otx3, Otx1 and Otx2 are expressed in the restricted regions of the developing forebrain and midbrain in early midgestation of mouse embryos as reported previously (3). In 9.5 dpc embryos, Otx1 is expressed intensely in the telencephalon, diencephalon, mesencephalon, and optic vesicles (Fig. 2A, A7). Otx2 is expressed in the telencephalon, diencephalon, and mesencephalon as well as in optic vesicles at 9.5 dpc (Fig. 2A, A4). At 10.5 dpc, Otx1 expression is still seen in the telencephalon, diencephalon, mesencephalon, and optic cups as in 9.5 dpc embryos (Fig. 2A, A8). Otx2 expression is observed in the diencephalon, mesencephalon, and optic cups as is Otx3, but Otx2 is only barely visible in the telencephalon at 10.5 dpc (Fig. 2A, A5). In 11.5 dpc embryos, Otx1 is expressed in the telencephalon as well as the diencephalon, mesencephalon, and developing eye (Fig. 2A, A9), while Otx2 expression is restricted to the mesencephalon and optic cups (Fig. 2A, A6). The expression patterns of Otx3, Otx2, and Otx1 are schematically summarized by a line diagram in Fig. 2A, A10 (9.5 dpc), A11 (10.5 dpc), and A12 (11.5 dpc). All three genes are expressed in the mesencephalon and diencephalon throughout these stages, while only Otx3 is expressed in the metencephalon and myelencephalon at 11.5 dpc.

DNA Binding Activity of Otx3 Protein-- The Otx family has lysine at the 50th position of the HD, which confers DNA binding specificity for the sequence motif TAATC(C/T) (the consensus for Otx1 and Otx2) or TAATC(C/A) (the consensus for Crx) (5, 7, 12). The binding of Otx3 to the motif TAATCC was tested using EMSA. A fusion protein of GST and the HD of Otx3 was incubated with radiolabeled DNA probes. Otx3 HD showed strong binding to the HD consensus sequence in Fig. 3A, lane 3. Fusion protein GST-Otx2 was used as a positive control. Specificity of Otx3 binding to the HD consensus sequence was examined by a competition experiment. The excess amount of unlabeled competitor of the HD consensus sequence resulted in a remarkable inhibition of the DNA binding activity of Otx3. However, binding was not inhibited by competition with the mutant HD consensus sequence (Fig. 3B).


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 3.   EMSA (A and B) and transcriptional analysis (C) of Otx3 protein in GH3 cells. A, in lane 1, radiolabeled oligonucleotide probes were incubated without the protein. In lane 2, radiolabeled oligonucleotide probes were incubated with GST-Otx2 fusion protein. In lane 3, radiolabeled oligonucleotide probes were incubated with GST-Otx3 fusion protein. The arrow indicates a shifted band. B, the unlabeled HD consensus sequence (TAATCC) was co-incubated as a competitor at increasing molar excess relative to the labeled probe in lanes 2-5 (1-, 10-, 20-, and 30-fold molar excess in lanes 2-5, respectively). The mutant HD consensus sequence was included as a competitor at increasing molar excess relative to the labeled probe in lanes 6-9 (1-, 10-, 20-, and 30-fold molar excess in lanes 6-9, respectively). C, relative luciferase activity of Otx3, Otx2, Otx2 plus Otx3, and Otx3N/Otx2C. Values are expressed as percentage relative to basal level (100%). Results were obtained from four independent experiments (n = 13-18). The single asterisk (*) indicates luciferase activity that is significantly different from the basal level (p < 0.0001). The double asterisk (**) shows the statistical significance (p < 0.001) as indicated.

Transcriptional Activity of Otx3-- To assay the activity of Otx3 as a transcription factor, a transcription reporter assay was performed in the neuroendocrine cell line GH3. Co-transfection of the cells with pP3Ctk-Luc and pCMV-Otx2 stimulated luciferase activity to 29-fold the activity in cells transfected with pP3Ctk-Luc alone (basal activity). When the cells were co-transfected with pP3Ctk-Luc and pCMV-Otx3, luciferase expression was suppressed to 36.6 ± 5.7% of the basal level (Fig. 3C). When the cells were co-transfected with pCMV-Otx3 and pCMV-Otx2 at a 1:1 ratio, reporter activity was suppressed to one-third the activity from Otx2 alone. This suggests that Otx3 functions as a transcription repressor of the Otx2 by acting competitively on the consensus sequence. We also generated a chimeric construct consisting of Otx3 and Otx2, in which the C terminus of Otx3 is replaced with that of Otx2. This replacement results in the reversion of Otx3 to an activator (438.6 ± 63.1%) from a repressor (36.6 ± 5.7%).

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

We have identified a novel transcription factor, Otx3. Otx3 contains a Bcd-like HD that is conserved among HD proteins, including the Drosophila anterior morphogen Bcd (13), otd (14), and its vertebrate homologues, the Otx family (Otx1, Otx2, and Crx) (5, 7), Goosecoid (Gsc) (15, 16), and vertebrate Ptx1 (17). The sequence similarities between Otx3 and Otx1, Otx2, and Crx indicate that Otx3 is structurally related to these members of the Otx family. In addition, the conservation of lysine in HD also suggests that Otx3 is a member of the Otx family. We examined mRNA expression of Otx3 by Northern blot analysis of adult tissues and clonal cell lines and found that Otx3 was most abundantly expressed in brain rather than in the endocrine pancreas. Temporal and spatial expression patterns of Otx3 during embryogenesis were further investigated in mouse embryos by Northern blotting and whole-mount in situ analyses. During embryogenesis, Otx3 mRNA expression was detected first at day 8.5 dpc and was most abundant from 9.5 to 11.5 dpc. During this developmental period, Otx1 and Otx2 have been shown to be expressed and to participate in brain morphogenesis (3). Whole-mount in situ hybridization was performed at different embryonic stages from 8.5 to 11.5 dpc. At day 8.5 dpc, Otx3 was expressed in the prospective midbrain region and preoptic placode. At day 9.5-11.5 dpc, the high level expression of Otx3 in the head became restricted to the diencephalon, mesencephalon, and developing eye, although it was also expressed in the metencephalon and myelencephalon. The spatial expression pattern of Otx3 during mouse embryogenesis largely overlapped that of Otx1 and Otx2. Otx1 and Otx2 are thought to cooperate in brain morphogenesis (18); studies of knockout mice (Otx1-/-Otx2+/- mice (19) and Otx1+/-Otx2+/- mice (20)) indicate that the Otx gene dosage is critical in correct positioning of the isthmic organizer. At this midbrain-hindbrain boundary, Otx3 expression showed the most intense hybridization signal during brain developmental stages. This finding suggests that Otx3 together with Otx1 or Otx2 may be involved in positioning in this area. Since the resemblance in the expression patterns of Otx3, Otx1, and Otx2 should reflect their functional similarities, we examined the DNA binding properties and the transcriptional activity of Otx3. As previously reported, lysine at position 50 in the HD is critical for DNA binding; the substitution of the lysine of the Bcd with glutamine has been shown to result in the loss of DNA binding specificity (12). Because all of these HD proteins recognize the same binding sites with high specificity (12, 21), we assumed that Otx3 would bind to the consensus sequences of Bcd-like HD proteins by interaction with the HD domain of Otx3. Indeed EMSA revealed that Otx3 specifically binds to the consensus sequence TAATCC. In addition, EMSA showed that Otx3 also binds to TAATCA, the consensus sequence for Crx (data not shown). We next determined whether or not Otx3 acts as a transcription factor using a luciferase reporter assay in GH3 cells. Otx3 was shown to act as a transcription factor by binding to the TAATCC sequence. The result of the luciferase reporter assay showed that Otx3 represses the transcription activity triggered by the tk minimal promoter. In addition, the reporter assay of the co-transfection experiments with Otx3 and Otx2 showed that Otx3 significantly suppressed Otx2-induced transcription activity, suggesting that Otx3 functions as a transcription repressor of Otx2 by acting competitively on the target sequence. Interestingly Otx3 lacks the "OTX-tail," a conserved motif of about 20 amino acids that is generally believed to confer transactivation activity in the Otx family (7, 22). In addition, the motif contains an alanine-rich region in the C terminus that is similar to the repression domain in some Drosophila transcription repressors, including Gsc (15, 16), Engrailed (En), Eve, and kruppel (kr) (23), and may be an important feature of repressor proteins (23). In each case, the repressor domain consists of at least 26% alanine residues, while 33% of the residues of the alanine-rich domain were alanine in Otx3. In addition, replacing the C terminus of Otx3 with that of Otx2 changed the transcriptional character of Otx3 from repressor to activator. Together these findings suggest that the C terminus of Otx3 acts as a transcription repressor, but further experiments are required to establish that Otx3 functions as a repressor of brain function.

It should be noted that the spatial and temporal expression patterns of Otx3, Otx1, and Otx2 are similar but not identical. At 9.5 dpc, Otx3 was not expressed in telencephalon, while both Otx1 and Otx2 were expressed in this area. At 10.5 and 11.5 dpc, the expression pattern of Otx3 resembled that of Otx2 but not Otx1 as assessed by whole-mount in situ hybridization. Analysis of in situ hybridization in sections at 13.5 dpc showed that the expression pattern of Otx3 in the myelencephalon was distinct from those of Otx1 and Otx2. Thus, Otx3 expression is craniocaudally more restricted than Otx1 and Otx2. Furthermore, the phenotypes of Otx1 (Otx1-/-) and Otx2 (Otx2-/-) knockout mice are different: Otx2-/- mice lack forebrain and midbrain, which is embryonically lethal (24, 25); Otx1-/- mice are viable but exhibit epilepsy, transient dwarfism, transient hypogonadism, and abnormality in inner ear and eyes (6, 26). Accordingly, although Otx3 is likely involved in brain morphogenesis in concert with Otx1 and Otx2, it may have a functionally distinct role from that Otx1 and Otx2.

    FOOTNOTES

* This work was supported by grants-in-aid for creative scientific research and for scientific research from the Ministry of Education, Culture, Sports, Science and Technology; by a scientific research grant from the Ministry of Health, Labor and Welfare, Japan; by grants from Novo Nordisk Pharma Ltd. and from Takeda Chemical Industries Ltd.; and by the Yamanouchi Foundation for Research on Metabolic Disorders.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AB037698 and AB037699.

** To whom correspondence should be addressed. Tel.: 81-43-226-2187; Fax: 81-43-221-7803; E-mail: seino@med.m.chiba-u.ac.jp.

Published, JBC Papers in Press, June 7, 2002, DOI 10.1074/jbc.C100767200

    ABBREVIATIONS

The abbreviations used are: CNS, central nervous system; HD, homeodomain; dpc, days postcoitum; EMSA, electrophoretic mobility shift assay; otd, orthodenticle; Bcd, bicoid; tk, thymidine kinase; Gsc, Goosecoid; En, Engrailed; kr, krupple, nt, nucleotides; aa, amino acids; GST, glutathione S-transferase; beta -gal, beta -galactosidase.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Lemaire, P., and Kodjabachian, L. (1996) Trends. Genet. 12, 525-531[CrossRef][Medline] [Order article via Infotrieve]
2. Tam, P. P., and Behringer, R. R. (1997) Mech. Dev. 68, 3-25[CrossRef][Medline] [Order article via Infotrieve]
3. Acampora, D., Gulisano, M., Broccoli, V., and Simeone, A. (2001) Prog. Neurobiol. 64, 69-95[CrossRef][Medline] [Order article via Infotrieve]
4. Simeone, A., Acampora, D., Gulisano, M., Stornaiuolo, A., and Boncinelli, E. (1992) Nature 358, 687-690[CrossRef][Medline] [Order article via Infotrieve]
5. Simeone, A., Acampora, D., Mallamaci, A., Stornaiuolo, A., D'Apice, M. R., Nigro, V., and Boncinelli, E. (1993) EMBO J. 12, 2735-2747[Medline] [Order article via Infotrieve]
6. Acampora, D., Mazan, S., Tuorto, F., Avantaggiato, V., Tremblay, J. J., Lazzaro, D., di Carlo, A., Mariano, A., Macchia, P. E., Corte, G., Macchia, V., Drouin, J., Brulet, P., and Simeone, A. (1998) Development 125, 1229-1239[Abstract]
7. Furukawa, T., Morrow, E. M., and Cepko, C. L. (1997) Cell 91, 531-541[CrossRef][Medline] [Order article via Infotrieve]
8. Szeto, D. P., Rodriguez-Esteban, C., Ryan, A. K., O'Connell, S. M., Liu, F., Kioussi, C., Gleiberman, A. S., Izpisua-Belmonte, J. C., and Rosenfeld, M. G. (1999) Genes Dev. 13, 484-494[Abstract/Free Full Text]
9. Edlund, H. (1998) Diabetes 47, 1817-1823[Abstract]
10. Akasaka, T., van Lohuizen, M., van der Lugt, N., Mizutani-Koseki, Y., Kanno, M., Taniguchi, M., Vidal, M., Alkema, M., Berns, A., and Koseki, H. (2001) Development 128, 1587-1597[Abstract]
11. Wilson, D., Sheng, G., Lecuit, T., Dostatni, N., and Desplan, C. (1993) Genes Dev. 7, 2120-2134[Abstract/Free Full Text]
12. Treisman, J., Gonczy, P., Vashishtha, M., Harris, E., and Desplan, C. (1989) Cell 59, 553-562[CrossRef][Medline] [Order article via Infotrieve]
13. Berleth, T., Burri, M., Thoma, G., Bopp, D., Richstein, S., Frigerio, G., Noll, M., and Nusslein-Volhard, C. (1988) EMBO J. 7, 1749-1756[Medline] [Order article via Infotrieve]
14. Finkelstein, R., Smouse, D., Capaci, T. M., Spradling, A. C., and Perrimon, N. (1990) Genes Dev. 4, 1516-1527[Abstract/Free Full Text]
15. Mailhos, C., Andre, S., Mollereau, B., Goriely, A., Hemmati-Brivanlou, A., and Desplan, C. (1998) Development 125, 937-947[Abstract]
16. Goriely, A., Stella, M., Coffinier, C., Kessler, D., Mailhos, C., Dessain, S., and Desplan, C. (1996) Development 122, 1641-1650[Abstract]
17. Lamonerie, T., Tremblay, J. J., Lanctot, C., Therrien, M., Gauthier, Y., and Drouin, J. (1996) Genes Dev. 10, 1284-1295[Abstract/Free Full Text]
18. Suda, Y., Matsuo, I., and Aizawa, S. (1997) Mech. Dev. 69, 125-141[CrossRef][Medline] [Order article via Infotrieve]
19. Acampora, D., Avantaggiato, V., Tuorto, F., and Simeone, A. (1997) Development 124, 3639-3650[Abstract]
20. Suda, Y., Nakabayashi, J., Matsuo, I., and Aizawa, S. (1999) Development 126, 743-757[Abstract]
21. Hanes, S. D., and Brent, R. (1989) Cell 57, 1275-1283[CrossRef][Medline] [Order article via Infotrieve]
22. Chau, K. Y., Chen, S., Zack, D. J., and Ono, S. J. (2000) J. Biol. Chem. 275, 37264-37270[Abstract/Free Full Text]
23. Han, K., and Manley, J. L. (1993) EMBO J. 12, 2723-2733[Medline] [Order article via Infotrieve]
24. Acampora, D., Mazan, S., Lallemand, Y., Avantaggiato, V., Maury, M., Simeone, A., and Brulet, P. (1995) Development 121, 3279-3290[Abstract]
25. Matsuo, I., Kuratani, S., Kimura, C., Takeda, N., and Aizawa, S. (1995) Genes Dev. 9, 2646-2658[Abstract/Free Full Text]
26. Acampora, D., Mazan, S., Avantaggiato, V., Barone, P., Tuorto, F., Lallemand, Y., Brulet, P., and Simeone, A. (1996) Nat. Genet. 14, 218-222[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Seino, T. Miki, H. Kiyonari, T. Abe, W. Fujimoto, K. Kimura, A. Takeuchi, Y. Takahashi, Y. Oiso, T. Iwanaga, et al.
Isx Participates in the Maintenance of Vitamin A Metabolism by Regulation of {beta}-Carotene 15,15'-Monooxygenase (Bcmo1) Expression
J. Biol. Chem., February 22, 2008; 283(8): 4905 - 4911.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
W. Fujimoto, T. Shiuchi, T. Miki, Y. Minokoshi, Y. Takahashi, A. Takeuchi, K. Kimura, M. Saito, T. Iwanaga, and S. Seino
Dmbx1 is essential in agouti-related protein action
PNAS, September 25, 2007; 104(39): 15514 - 15519.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
T. Takahashi and P. W. H. Holland
Amphioxus and ascidian Dmbx homeobox genes give clues to the vertebrate origins of midbrain development
Development, July 15, 2004; 131(14): 3285 - 3294.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Levantini, A. Giorgetti, F. Cerisoli, E. Traggiai, A. Guidi, R. Martin, D. Acampora, P. D. Aplan, G. Keller, A. Simeone, et al.
Unsuspected role of the brain morphogenetic gene Otx1 in hematopoiesis
PNAS, September 2, 2003; 100(18): 10299 - 10303.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
A. S. Viczian, R. Vignali, M. E. Zuber, G. Barsacchi, and W. A. Harris
XOtx5b and XOtx2 regulate photoreceptor and bipolar fates in the Xenopus retina
Development, April 1, 2003; 130(7): 1281 - 1294.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/31/28065    most recent
C100767200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, Y.
Right arrow Articles by Seino, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, Y.
Right arrow Articles by Seino, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement